⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RNA News
Avidity Biosciences, Inc. Common Stock
Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration
prnewswire.com
BMY
RNA
Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
prnewswire.com
RNA
Atrium Therapeutics Launches with Approximately $270 Million to Advance Novel RNA Medicines for Rare Genetic Cardiomyopathies
prnewswire.com
RNA
Form 8-K
sec.gov
RNAM
RNA
Novartis successfully completes acquisition of Avidity Biosciences, strengthening late-stage neuroscience pipeline and advancing xRNA strategy
globenewswire.com
NVS
RNA
Form 8-K
sec.gov
RNA
Avidity Biosciences Announces Multiple Upcoming Presentations at 2026 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
prnewswire.com
RNA
Form 8-K
sec.gov
RNA
Avidity Biosciences Announces Intention to Adjourn and Reconvene Special Meeting of Stockholders
prnewswire.com
RNA
The New England Journal of Medicine Publishes Results from Phase 1/2 MARINA® Trial of Delpacibart Etedesiran (del-desiran) for Treatment of Myotonic Dystrophy Type 1
prnewswire.com
RNA